Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

Caitlin E. Cox

July 23, 2024

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

Todd Neale

July 04, 2022

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

News Daily News

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

Todd Neale

January 20, 2021

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

Recent Stroke Heightens Risk of Perioperative Events After AVR

Todd Neale

April 25, 2018

News Daily News

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Shelley Wood

September 13, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Daily News

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Michael O'Riordan

May 02, 2016

News Daily News

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

L.A. McKeown

April 21, 2016

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

Recent Stroke Heightens Risk of Perioperative Events After AVR

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content